Chronos Archive seal
The Human Record

Ernest Shackleton

Case HR-EX001 · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
February 15, 1874 – January 5, 1922
Synthetic DOB
1979-02-15
Index visit
2026-05-12 at age 47
Synthetic MRN
HR-EX001-SYN

Teaching objective: Primary care and cardiology for a 47-year-old expedition leader and heavy smoker with new exertional chest tightness and breathlessness, four months before leading a ship-based polar expedition: pretest probability and risk assessment, a resting ECG and risk-factor tests, coronary CT angiography with CT-FFR as the first test, an echocardiogram, guideline-directed medical therapy (aspirin, high-intensity statin with ezetimibe to an LDL below 55 mg/dL, a beta-blocker, and sublingual nitroglycerin), revascularization when angina persists despite medical therapy and what it does and does not offer in chronic coronary disease, dual antiplatelet therapy, cardiac rehabilitation, varenicline with counseling, the AUDIT with a brief intervention, prediabetes, and fitness for remote high-latitude travel: a symptom-limited exercise test, an evacuation plan, a defibrillator and medicines on board, and cold stress. His reluctance to be examined, and to let anything stop the expedition, is worked through with shared decision-making. Built on the 2023 AHA/ACC chronic coronary disease guideline, the 2024 ESC chronic coronary syndromes guideline, and the CMID ischemic heart disease and hyperlipidemia monographs.

Historical timeline

DateEventClaims
February 15, 1874Born at Kilkea, County Kildare.CLM-0001
1903Invalided home from the Discovery expedition after breathlessness and weakness on the southern journey.CLM-0002
January 20, 1908On the Nimrod expedition, very unwell after pulling on a rope; a pulmonary systolic murmur heard.CLM-0003
1914 to 1917Endurance expedition; three men of the Ross Sea party died.CLM-0004
1921Organized the Shackleton-Rowett expedition in London.CLM-0007
September 17, 1921The Quest left London.CLM-0007
December 1921Sudden faintness ashore at Rio de Janeiro.CLM-0008
January 5, 1922Died aboard the Quest at Grytviken; Macklin recorded atheroma of the coronary arteries.CLM-0009, CLM-0010, CLM-0011
March 5, 1922Buried at Grytviken.CLM-0012

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D Ernest Henry Shackleton was born on February 15, 1874, at Kilkea, County Kildare, Ireland, the son of Dr. Henry Shackleton, of a well-known Quaker family. confirmed Death of Ernest Shackleton (Kildare eHistory Journal) supports
Shackleton, Ernest Henry, Sir, 1874-1922 (name authority record n50002512) supports
D On the southern sledge journey of the Discovery expedition he became unable to pull the sledge because of breathlessness and weakness; the collapse was attributed to scurvy and "a sort of asthma," and he was invalided home against his will in 1903.
Documented exertional breathlessness in his late twenties. Its cause is disputed (CLM-0010, CLM-0011).
confirmed Calder I, Till J. Shackleton's heart. J R Soc Med 2016;109(3):106-8. PMID 26759361 supports
Firth PG, Benavidez OJ, Fiechtner L. The signs and symptoms of Ernest Shackleton. J Med Biogr 2023;31(1):10-15. PMID 33896263 supports
Wild F, with Macklin AH. Shackleton's Last Voyage: The Story of the Quest. London, 1923. Project Gutenberg eBook 58973 supports
D On the Nimrod expedition (1907 to 1909), its medical officer Eric Marshall recorded in his diary on January 20, 1908, that Shackleton was very unwell after pulling on a rope, and twice heard a pulmonary systolic murmur.
Documented exertional illness and a heart murmur in his thirties; the cause is disputed.
confirmed Calder I, Till J. Shackleton's heart. J R Soc Med 2016;109(3):106-8. PMID 26759361 supports
D On the Imperial Trans-Antarctic (Endurance) expedition of 1914 to 1917, of fifty-six men three died in the Antarctic: Mackintosh, Hayward, and Spencer-Smith of the Ross Sea party. No member of the Endurance's own party died.
After this, he wrote South, published in 1919; not a clinical claim.
confirmed Shackleton EH. South: The Story of Shackleton's Last Expedition, 1914-1917. London, 1919. Project Gutenberg eBook 5199 supports
D His colleague Dr. James McIlroy later recalled that on one occasion Shackleton would not undress and let him listen to his heart.
A recollection quoted in a later essay; the year is not used. Anchors the modern episode's reluctance to be examined, which is worked through by shared decision-making.
probable Calder I, Till J. Shackleton's heart. J R Soc Med 2016;109(3):106-8. PMID 26759361 supports
D He was a heavy cigarette smoker for most of his life.
Stated by the authors of a 2016 essay on his heart; the synthetic smoking history is anchored to it.
probable Calder I, Till J. Shackleton's heart. J R Soc Med 2016;109(3):106-8. PMID 26759361 supports
D After the war he returned to London. In 1921, with John Quiller Rowett taking on practically the whole financial responsibility, he turned his planned Arctic expedition into the Shackleton-Rowett expedition to the South; it was organized and equipped within three months, its sailing was postponed beyond August 20 by a strike of ships' joiners and other delays, and the Quest left St. Katharine's Dock in London on September 17, 1921.
Places him in London through the synthetic episode, which ends before the sailing.
confirmed Wild F, with Macklin AH. Shackleton's Last Voyage: The Story of the Quest. London, 1923. Project Gutenberg eBook 58973 supports
D In Rio de Janeiro, on the morning the Quest sailed in December 1921, an urgent message called Dr. Alexander Macklin to Shackleton, who had been taken suddenly ill ashore; Macklin found him fully recovered, saying he had merely felt a slight faintness. Frank Wild wrote that "this attack had a greater significance than was appreciated at the time." At the end of December, Macklin noticed that he was looking tired and ill.
After the episode.
confirmed Wild F, with Macklin AH. Shackleton's Last Voyage: The Story of the Quest. London, 1923. Project Gutenberg eBook 58973 supports
Death of Shackleton supports
D At South Georgia, early on January 5, 1922, aboard the Quest at Grytviken, he called Macklin to his cabin, complaining of severe facial neuralgia for which he had taken aspirin; while Macklin was with him he had an attack and died suddenly, at about 2.50 a.m. Macklin wrote that the cause was "atheroma of the coronary arteries," a long-standing condition that in his opinion was due to overstrain during a period of debility. At embalming Macklin could see the heart, but no further pathological examination was feasible.
After the episode. Macklin's wording is documented; the autopsy was not a full pathological examination.
confirmed Wild F, with Macklin AH. Shackleton's Last Voyage: The Story of the Quest. London, 1923. Project Gutenberg eBook 58973 supports
Calder I, Till J. Shackleton's heart. J R Soc Med 2016;109(3):106-8. PMID 26759361 supports
Death of Ernest Shackleton (Kildare eHistory Journal) supports
Death of Shackleton supports
R Two authors argue that his breakdowns, beginning with the Discovery journey, were caused by a congenital atrial septal defect, citing the pulmonary systolic murmur and his episodes of breathlessness and weakness.
Retrospective interpretation; the modern echocardiogram shows no shunt and the record does not adopt it.
possible Calder I, Till J. Shackleton's heart. J R Soc Med 2016;109(3):106-8. PMID 26759361 supports
R Other authors propose that the illness on the Discovery expedition was thiamine-deficiency (beriberi) cardiomyopathy, alone or worsened by scurvy.
Retrospective interpretation; not adopted.
possible Firth PG, Benavidez OJ, Fiechtner L. The signs and symptoms of Ernest Shackleton. J Med Biogr 2023;31(1):10-15. PMID 33896263 supports
D At the wish of Lady Shackleton he was buried at Grytviken, South Georgia, on March 5, 1922.
After the episode. His wife appears only in this documented claim.
confirmed Death of Shackleton supports

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S Chest tightness and breathlessness on exertion for about three months, brought on by stairs, carrying loads, and walking fast in cold wind and relieved within minutes by rest, never at rest; resting ECG normal; cause not yet established at intake; coronary CT angiography and cardiology consultation requested resolved confirmed active CLM-0002, CLM-0003, CLM-0006
S Nicotine dependence, cigarettes: about 25 a day since 16 (about 39 pack-years) active confirmed both_with_link CLM-0006
S Chronic coronary disease with stable exertional angina: 80% stenosis of the proximal left anterior descending artery with CT-FFR 0.70, mild right coronary artery disease, coronary calcium score 210, and normal left ventricular function; synthetic modern episode linked to his documented exertional illnesses and the coronary atheroma recorded at his death active confirmed both_with_link CLM-0002, CLM-0003, CLM-0006
S Hyperlipidemia: LDL cholesterol 168 mg/dL and HDL 38 mg/dL at intake active confirmed active
S Prediabetes: HbA1c 5.9% at intake active confirmed active
S Drug-eluting stent in the proximal left anterior descending artery, placed for angina that persisted on medical therapy; dual antiplatelet therapy for six months active confirmed active CLM-0002, CLM-0003, CLM-0006
S Acute low back strain after lifting crates of stores, without sciatica or red flags; managed without NSAIDs because he takes aspirin and clopidogrel; resolved resolved confirmed active

Synthetic outcome measures

GradeDateMeasureResultCoding
S 2026-05-12 Cholesterol [Mass/volume] in Serum or Plasma 246 mg/dL (high)
Reference <=199 mg/dL
http://loinc.org · 2093-3
S 2026-05-12 Cholesterol in HDL [Mass/volume] in Serum or Plasma 38 mg/dL (low)
Reference >=40 mg/dL
http://loinc.org · 2085-9
S 2026-05-12 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 168 mg/dL (high)
Reference Below 100 for the general population; below 55 is his treatment target
http://loinc.org · 13457-7
S 2026-05-12 Triglyceride [Mass/volume] in Serum or Plasma 200 mg/dL (high)
Reference <=149 mg/dL
http://loinc.org · 2571-8
S 2026-05-12 Hemoglobin A1c/Hemoglobin.total in Blood 5.9% (high)
Reference <=5.6%
http://loinc.org · 4548-4
S 2026-05-12 Potassium [Moles/volume] in Serum or Plasma 4.4 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-05-12 Creatinine [Mass/volume] in Serum or Plasma 0.98 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 2026-05-12 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 41 U/L
Reference 7-52 U/L
http://loinc.org · 1742-6
S 2026-05-12 Hemoglobin [Mass/volume] in Blood 15.8 g/dL
Reference 13.2-17.1 g/dL
http://loinc.org · 718-7
S 2026-05-12 Thyrotropin [Units/volume] in Serum or Plasma 1.9 mIU/L
Reference 0.45-4.5 mIU/L
http://loinc.org · 3016-3
S 2026-05-12 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 96 mL/min/1.73 m²
Reference 60 or more
http://loinc.org · 98979-8
S 2026-05-12 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 http://loinc.org · 55758-7
S 2026-05-12 Total score [AUDIT] 12 http://loinc.org · 75624-7
S 2026-05-26 Left ventricular Ejection fraction 58%
Reference 52-72%
http://loinc.org · 10230-1
S 2026-06-23 Potassium [Moles/volume] in Serum or Plasma 4.3 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-06-23 Creatinine [Mass/volume] in Serum or Plasma 0.96 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 2026-06-23 Hemoglobin [Mass/volume] in Blood 15.6 g/dL
Reference 13.2-17.1 g/dL
http://loinc.org · 718-7
S 2026-06-23 Platelets [#/volume] in Blood by Automated count 245 10*3/uL
Reference 140-400 10*3/uL
http://loinc.org · 777-3
S 2026-06-23 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 98 mL/min/1.73 m²
Reference 60 or more
http://loinc.org · 98979-8
S 2026-07-21 Cholesterol [Mass/volume] in Serum or Plasma 128 mg/dL
Reference <=199 mg/dL
http://loinc.org · 2093-3
S 2026-07-21 Cholesterol in HDL [Mass/volume] in Serum or Plasma 44 mg/dL
Reference >=40 mg/dL
http://loinc.org · 2085-9
S 2026-07-21 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 62 mg/dL
Reference Below 100 for the general population; below 55 is his treatment target
http://loinc.org · 13457-7
S 2026-07-21 Triglyceride [Mass/volume] in Serum or Plasma 110 mg/dL
Reference <=149 mg/dL
http://loinc.org · 2571-8
S 2026-07-21 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 31 U/L
Reference 7-52 U/L
http://loinc.org · 1742-6
S 2026-07-21 Total score [AUDIT-C] 4 http://loinc.org · 75626-2
S 2026-09-08 Cholesterol [Mass/volume] in Serum or Plasma 108 mg/dL
Reference <=199 mg/dL
http://loinc.org · 2093-3
S 2026-09-08 Cholesterol in HDL [Mass/volume] in Serum or Plasma 45 mg/dL
Reference >=40 mg/dL
http://loinc.org · 2085-9
S 2026-09-08 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 44 mg/dL
Reference Below 100 for the general population; below 55 is his treatment target
http://loinc.org · 13457-7
S 2026-09-08 Triglyceride [Mass/volume] in Serum or Plasma 95 mg/dL
Reference <=149 mg/dL
http://loinc.org · 2571-8
S 2026-09-08 Hemoglobin A1c/Hemoglobin.total in Blood 5.7% (high)
Reference <=5.6%
http://loinc.org · 4548-4
S 2026-09-08 Total score [AUDIT-C] 3 http://loinc.org · 75626-2
S 2026-08-11 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 http://loinc.org · 55758-7

Synthetic vital signs

DateMeasureResultLOINCGrade
2026-05-12Body height175 cm8302-2S
2026-05-12Body weight86 kg29463-7S
2026-05-12Body mass index (BMI) [Ratio]28.1 kg/m239156-5S
2026-05-12Systolic blood pressure138 mm[Hg]8480-6S
2026-05-12Diastolic blood pressure86 mm[Hg]8462-4S
2026-05-12Heart rate78 /min8867-4S
2026-05-12Respiratory rate16 /min9279-1S
2026-05-12Body temperature36.7 Cel8310-5S
2026-05-12Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S
2026-05-26Body height175 cm8302-2S
2026-05-26Body weight85.6 kg29463-7S
2026-05-26Body mass index (BMI) [Ratio]28 kg/m239156-5S
2026-05-26Systolic blood pressure134 mm[Hg]8480-6S
2026-05-26Diastolic blood pressure84 mm[Hg]8462-4S
2026-05-26Heart rate66 /min8867-4S
2026-05-26Respiratory rate14 /min9279-1S
2026-05-26Body temperature36.6 Cel8310-5S
2026-05-26Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S
2026-06-23Body height175 cm8302-2S
2026-06-23Body weight85 kg29463-7S
2026-06-23Body mass index (BMI) [Ratio]27.8 kg/m239156-5S
2026-06-23Systolic blood pressure128 mm[Hg]8480-6S
2026-06-23Diastolic blood pressure80 mm[Hg]8462-4S
2026-06-23Heart rate60 /min8867-4S
2026-06-23Respiratory rate14 /min9279-1S
2026-06-23Body temperature36.6 Cel8310-5S
2026-06-23Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-07-21Body height175 cm8302-2S
2026-07-21Body weight84.4 kg29463-7S
2026-07-21Body mass index (BMI) [Ratio]27.6 kg/m239156-5S
2026-07-21Systolic blood pressure124 mm[Hg]8480-6S
2026-07-21Diastolic blood pressure78 mm[Hg]8462-4S
2026-07-21Heart rate58 /min8867-4S
2026-07-21Respiratory rate14 /min9279-1S
2026-07-21Body temperature36.7 Cel8310-5S
2026-07-21Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-09-08Body height175 cm8302-2S
2026-09-08Body weight83 kg29463-7S
2026-09-08Body mass index (BMI) [Ratio]27.1 kg/m239156-5S
2026-09-08Systolic blood pressure120 mm[Hg]8480-6S
2026-09-08Diastolic blood pressure76 mm[Hg]8462-4S
2026-09-08Heart rate58 /min8867-4S
2026-09-08Respiratory rate14 /min9279-1S
2026-09-08Body temperature36.6 Cel8310-5S
2026-09-08Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-08-11Body height175 cm8302-2S
2026-08-11Body weight83.8 kg29463-7S
2026-08-11Body mass index (BMI) [Ratio]27.4 kg/m239156-5S
2026-08-11Systolic blood pressure122 mm[Hg]8480-6S
2026-08-11Diastolic blood pressure76 mm[Hg]8462-4S
2026-08-11Heart rate60 /min8867-4S
2026-08-11Respiratory rate14 /min9279-1S
2026-08-11Body temperature36.6 Cel8310-5S
2026-08-11Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-08-25Body height175 cm8302-2S
2026-08-25Body weight83.5 kg29463-7S
2026-08-25Body mass index (BMI) [Ratio]27.3 kg/m239156-5S
2026-08-25Systolic blood pressure130 mm[Hg]8480-6S
2026-08-25Diastolic blood pressure82 mm[Hg]8462-4S
2026-08-25Heart rate70 /min8867-4S
2026-08-25Respiratory rate16 /min9279-1S
2026-08-25Body temperature36.7 Cel8310-5S
2026-08-25Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.

Care-plan goals

GoalTarget dateStatusOutcome
No cigarettes from the quit date, confirmed at each visit2026-09-08completedNot smoked since the quit date a week after intake; varenicline continued to 24 weeks
LDL cholesterol below 55 mg/dL with at least a 50% reduction by four months2026-09-08completed44 mg/dL, from 168
Blood pressure below 130/80 mmHg by six weeks2026-06-23completed128/80 at six weeks
Free of angina in daily activity, and a symptom-limited exercise test of at least 10 METs without ischemia before departure2026-09-08completedNo angina since the stent; about 12.8 METs without angina or ST changes
Drinking within the low-risk limit, with an AUDIT-C below 4, by four months2026-09-08completedAUDIT-C 3, from an AUDIT of 12; two drinks at most on four evenings a week
At least 15 sessions of cardiac rehabilitation before departure2026-09-08completed18 sessions completed

Interventions

InterventionStatusGuideline
Cardiology consultation in two weeks with coronary CT angiography for suspected stable angina, and advice on revascularization and on fitness for the expeditioncompletedGL-AHA-CCD-2023, GL-ESC-CCS-2024
Medical therapy from intake for suspected angina: aspirin 81 mg, atorvastatin 80 mg, metoprolol succinate, and sublingual nitroglycerin with written instructions to call emergency services if pain lasts more than 5 minutes after the first dosecompletedGL-AHA-CCD-2023, GL-ESC-CCS-2024, GL-CMID-2026
Stop smoking: varenicline for 12 weeks, with the option of 12 more, a quit date in one week, counseling at each visit, and the quitlinecompletedGL-USPSTF-TOB-2021, GL-AHA-CCD-2023
AUDIT with a brief intervention for hazardous drinking: no more than two drinks a day and several alcohol-free days a week, with AUDIT-C at follow-upcompletedGL-USPSTF-ALC-2018, GL-AHA-CCD-2023
Prediabetes: diet and activity counseling and HbA1c in about four monthscompletedGL-USPSTF-DM-2021, GL-AHA-CCD-2023
Raise metoprolol succinate to 100 mg for persisting angina, with an echocardiogram, and revascularization of the proximal LAD lesion if angina persists despite medical therapy or he prefers it after a shared decisioncompletedGL-AHA-CCD-2023, GL-ESC-CCS-2024
Expedition plan: a symptom-limited exercise test before departure, a written cardiac summary with ECG and stent card, three months' extra medicines split between two bags, an automated external defibrillator and emergency cardiac medicines on board, a satellite link for telemedicine, an evacuation plan to the nearest cardiac centers along the route, and advice on cold stresscompletedGL-AHA-CCD-2023, GL-ESC-CCS-2024
Invasive coronary angiography with a drug-eluting stent to the proximal LAD, then aspirin with clopidogrel for six months and aspirin alone aftercompletedGL-AHA-CCD-2023, GL-ESC-CCS-2024
Cardiac rehabilitation after the stent, three sessions a week until departure, with a home exercise plan for the voyagecompletedGL-AHA-CCD-2023, GL-CMID-2026
Add ezetimibe 10 mg because LDL cholesterol was 62 mg/dL on atorvastatin 80 mg, above the target below 55completedGL-ESC-CCS-2024, GL-CMID-2026

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Death of Ernest Shackleton (Kildare eHistory Journal) Kildare Library and Arts Service, Kildare County Council government
SRC-0002 Shackleton, Ernest Henry, Sir, 1874-1922 (name authority record n50002512) Library of Congress government
SRC-0003 Wild F, with Macklin AH. Shackleton's Last Voyage: The Story of the Quest. London, 1923. Project Gutenberg eBook 58973 Project Gutenberg primary
SRC-0004 Calder I, Till J. Shackleton's heart. J R Soc Med 2016;109(3):106-8. PMID 26759361 Journal of the Royal Society of Medicine scholarly
SRC-0005 Firth PG, Benavidez OJ, Fiechtner L. The signs and symptoms of Ernest Shackleton. J Med Biogr 2023;31(1):10-15. PMID 33896263 Journal of Medical Biography scholarly
SRC-0006 Shackleton EH. South: The Story of Shackleton's Last Expedition, 1914-1917. London, 1919. Project Gutenberg eBook 5199 Project Gutenberg primary
SRC-0007 Death of Shackleton South Georgia Museum other
SRC-0008 HISTMED Master Roster v3 The Human Record project other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check coronary CT angiography as the first test, PCI for angina despite medical therapy in chronic coronary disease, six months of dual antiplatelet therapy on a remote expedition, the LDL target, and the expedition fitness plan.
provenance reviewnot_startedKildare County Council library article, Library of Congress authority record, the 1923 Quest narrative with Macklin's medical appendix and the 1919 South (Project Gutenberg), the South Georgia Museum, a full-text 2016 essay, and a PubMed abstract logged. The atrial septal defect and beriberi theories are graded R.
safe messaging reviewnot_startedNo behavioral-health diagnosis; hazardous drinking is synthetic, uncoded, and marked as not a claim about his real drinking.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.